US$ 25.25
are glp-1 drugs covered by medicare CMS Issues Coverage Guidance on Anti-Obesity White House GLP-1 Coverage Determination:
Description
In recent years, the gut-brain axis has been increasingly considered a promising topic for the study of CNS-related diseases because the gut microbiota and gut hormones have been shown to interact with other organs including the brain (Knight et al., 2017), although the mechanisms involved in gut homeostasis and brain function are as yet uncharacterized (Neufeld and Foster, 2009)

Finally, preclinical data suggest that treatment with GLP-1 RAs could result in lower incidence of NASH-related hepatocellular carcinoma (HCC) [100]

At each visit, all subjects underwent physical examination, body composition analysis and blood testing, as well as completed diet and physical activity questionnaires

Bodhale DW, Nisar A, Afzulpurkar N

GLP-1s: A long-term medication
